A conserved UDP-glucose dehydrogenase encoded outside the hasabc operon contributes to capsule biogenesis in group A Streptococcus

Journal of Bacteriology

Volumn 194, Issue 22, 2012, Pages 6154-6161

  Cole, Jason N ^a,b   Aziz, Ramy K ^a,c   Kuipers, Kirsten ^a,e   Timmer, Anjuli M ^a   Nizet, Victor ^a,d   van Sorge, Nina M ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c CAIRO UNIVERSITY   (Egypt)

^d RADY CHILDREN'S HOSPITAL   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; HASB PROTEIN; HASB2 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

ALLELE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BIOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; GENE DUPLICATION; GENE MUTATION; GENETIC SCREENING; MUTAGENESIS; OPERON; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; STREPTOCOCCUS GROUP A; SURVIVAL; SYNTHESIS;

AMINO ACID SEQUENCE; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOME, BACTERIAL; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; OPERON; PHYLOGENY; PROTEIN CONFORMATION; STREPTOCOCCUS PYOGENES; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS SP. 'GROUP A';

EID: 84869109970     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01317-12     Document Type: Article

References (49)

1. Alberti S, Ashbaugh CD, Wessels MR. 1998. Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol. Microbiol. 28:343-353.
2. Altschul SF, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Ashbaugh CD, Alberti S, Wessels MR. 1998. Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J. Bacteriol. 180:4955-4959.
4. Aziz RK, et al. 2010. Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence. PLoS One 5:e9798. doi:10.1371/ journal.pone.0009798.
5. Bernish B, van de Rijn I. 1999. Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production. J. Biol. Chem. 274:4786-4793.
6. Blank LM, Hugenholtz P, Nielsen LK. 2008. Evolution of the hyaluronic acid synthesis (has) operon in Streptococcus zooepidemicus and other pathogenic streptococci. J. Mol. Evol. 67:13-22.
7. Boulnois GJ, Roberts IS. 1990. Genetics of capsular polysaccharide production in bacteria. Curr. Top. Microbiol. Immunol. 150:1-18.
8. Campbell RE, Mosimann SC, van De Rijn I, Tanner ME, Strynadka NC. 2000. The first structure of UDP-glucose dehydrogenase reveals the catalytic residues necessary for the two-fold oxidation. Biochemistry 39:7012-7023.
9. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694.
10. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 9:724-736.
11. Cole JN, et al. 2010. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. mBio 1(4):e00191-10. doi:10.1128/ mBio.00191-10.
12. Crater DL, Dougherty BA, van de Rijn I. 1995. Molecular characterization of hasC from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose pyrophosphorylase activity. J. Biol. Chem. 270:28676-28680.
13. Crater DL, van de Rijn I. 1995. Hyaluronic acid synthesis operon (has) expression in group A streptococci. J. Biol. Chem. 270:18452-18458.
14. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
15. Cywes C, Stamenkovic I, Wessels MR. 2000. CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J. Clin. Invest. 106: 995-1002.
16. Dale JB, Washburn RG, Marques MB, Wessels MR. 1996. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 64:1495-1501.
17. Datta V, et al. 2005. Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol. Microbiol. 56:681-695.
18. DeAngelis PL, Papaconstantinou J, Weigel PH. 1993. Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria. J. Biol. Chem. 268: 14568-14571.
19. DeAngelis PL, Papaconstantinou J, Weigel PH. 1993. Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J. Biol. Chem. 268:19181-19184.
20. Dereeper A, et al. 2008. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36:W465-W469.
21. Dinkla K, et al. 2007. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related α2-macroglobulin-binding protein GRAB located on the bacterial surface. Microbes Infect. 9:922-931.
22. Dougherty BA, van de Rijn I. 1992. Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci. J. Exp. Med. 175:1291-1299.
23. Dougherty BA, van de Rijn I. 1994. Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. J. Biol. Chem. 269:169-175.
24. Dougherty BA, van de Rijn I. 1993. Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose dehydrogenase activity. J. Biol. Chem. 268:7118-7124.
25. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797.
26. Foley MJ, and Wood WB, Jr. 1959. Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J. Exp. Med. 110:617-628.
27. Froude J, Gibofsky A, Buskirk DR, Khanna A, Zabriskie JB. 1989. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity. Curr. Top. Microbiol. Immunol. 145: 5-26.
28. Graham MR, et al. 2002. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. U. S. A. 99:13855-13860.
29. Gryllos I, et al. 2001. Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol. Microbiol. 42:61-74.
30. Guindon S, Delsuc F, Dufayard JF, Gascuel O. 2009. Estimating maximum likelihood phylogenies with PhyML. Methods Mol. Biol. 537:113-137.
31. Hollands A, et al. 2010. Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A Streptococcus M1T1 clone. J. Infect. Dis. 202:11-19.
32. Johnson DA, et al. 2008. High-throughput phenotypic characterization of Pseudomonas aeruginosa membrane transport genes. PLoS Genet. 4:e1000211. doi:10.1371/journal.pgen.1000211.
33. Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. 2000. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68:6362-6369.
34. Kendall FE, Heidelberger M, Dawson MH. 1937. A serologically inactive polysaccharide elaborated by mucoid strains of group A hemolytic Streptococcus. J. Biol. Chem. 118:61-69.
35. Levin JC, Wessels MR. 1998. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol. Microbiol. 30:209-219.
36. Moses AE, et al. 1997. Relative contributions of hyaluronic acid capsule andMprotein to virulence in a mucoid strain of the groupAStreptococcus. Infect. Immun. 65:64-71.
37. Overbeek R, Bartels D, Vonstein V, Meyer F. 2007. Annotation of bacterial and archaeal genomes: improving accuracy and consistency. Chem. Rev. 107:3431-3447.
38. Pritzlaff CA, et al. 2001. Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol. Microbiol. 39:236-247.
39. Ravins M, et al. 2000. Characterization of a mouse-passaged, highly encapsulated variant of group A Streptococcus in in vitro and in vivo studies. J. Infect. Dis. 182:1702-1711.
40. Schrager HM, Alberti S, Cywes C, Dougherty GJ, Wessels MR. 1998. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of groupAStreptococcus to CD44 on human keratinocytes. J. Clin. Invest. 101:1708-1716.
41. Stollerman GH, Dale JB. 2008. The importance of the group A Streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin. Infect. Dis. 46:1038-1045.
42. Stoolmiller AC, Dorfman A. 1969. The biosynthesis of hyaluronic acid by Streptococcus. J. Biol. Chem. 244:236-246.
43. Sumby P, et al. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192:771-782.
44. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. 2006. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2:e5. doi:10.1371/journal.ppat.0020005.
45. Unnikrishnan M, et al. 2002. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J. Immunol. 169:2561-2569.
46. Wang Y, Geer LY, Chappey C, Kans JA, Bryant SH. 2000. Cn3D: sequence and structure views for Entrez. Trends Biochem. Sci. 25:300-302.
47. Wessels MR, Bronze MS. 1994. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc. Natl. Acad. Sci. U. S. A. 91:12238-12242.
48. Wessels MR, Goldberg JB, Moses AE, DiCesare TJ. 1994. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect. Immun. 62:433-441.
49. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. U. S. A. 88:8317-8321.